Three notices were published in the Federal Register of Feb. 5 relating to control of synthetic cannabinoids, a class of so-called designer drugs (81 Fed. Reg. 6171, 6175 and 6190). Synthetic cannabinoids are substances synthesized in laboratories that mimic the biological effects of delta-9-tetrahydrocannabinol (THC), the main psychoactive ingredient in marijuana. The temporary e... Read More